{"url_path":"/sec/nord/10-k/2026/item-10","section_key":"item-10","section_title":"Item 10 Directors, Executive Officers and Corporate Governance**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1011060/0001493152-26-033203-index.html","accession_number":"0001493152-26-033203","cik":"0001011060","ticker":"NORD","issuer_name":"Nordicus Partners Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1011060/0001493152-26-033203-index.html","primary_entity_key":"0001011060","primary_entity_name":"Nordicus Partners Corp"},"word_count":1670,"has_tables":true,"body_markdown":"** **\n\n**Item\n10. Directors, Executive Officers and Corporate Governance**\n\n \n\nThe\nfollowing persons served as our directors and executive officers for the fiscal years ended March 31, 2026 and 2025. Each director holds\noffice until the next annual meeting of the stockholders or until his successor has been duly elected and qualified. Each executive officer\nserves at the discretion of the Board of Directors of the Company.\n\n \n\nName \nAge \nPosition\n\nHenrik Rouf \n59 \nChief Executive Officer\n\nChristian Hill-Madsen (1) \n60 \nDirector\n\nBennett J. Yankowitz \n71 \nDirector and Chief Financial Officer\n\nHenrik Keller (2) \n71 \nDirector\n\nPeter Severin (3) \n62 \nDirector\n\nTorben S. Jensen (4) \n61 \nDirector\n\nKim T. Mücke (4) \n61 \nDirector\n\nAndrew J. Ritter (5) \n43 \nDirector (resigned effective July 7, 2026)\n\n \n\n \n(1)\nResigned\nfrom the Board on June 3, 2024.\n\n \n(2)\nResigned\nfrom the Board on August 7, 2025.\n\n \n(3)\nAppointed\nto the Board on June 3, 2024.\n\n \n(4)\nAppointed\nto the Board on August 7, 2025.\n\n \n(5)\nAppointed\nto the Board on August 7, 2025, resigned effective July 7, 2026.\n\n \n\nThere\nare no family relationships between our directors and executive officers.\n\n \n\n**Background\nof Executive Officers and Directors**\n\n \n\n*Henrik\nRouf—Chief Executive Officer*. Mr. Rouf has 30 years of experience in the global financial markets, working as an investment\nbanker and international financier. He currently advises public and private companies in various industries, including life sciences,\nAI, blockchain, and semiconductors, throughout North America, Europe, and India.\n\n \n\nPrior\nto joining Nordicus Partners as Chief Executive Officer, Mr. Rouf was the President of PWP, Inc., a California-based merchant bank, from\n2004 to 2023, where he ran the company’s overall investment banking practice. During this time, he also cofounded Rocketfuel Blockchain,\na global payment processing platform. From 1997 to 2004, he was the Managing Partner of Impact Capital and financed numerous micro-cap\nand small-cap companies. Mr. Rouf started his career in the U.S. in 1991 as an Institutional Broker for various brokerage houses in New\nYork and San Francisco, including Wedbush.\n\n \n\n*Peter\nSeverin – Chairman of our Board of Directors.* Mr. Severin is an experienced consultant in the pharmaceutical industry. He is\nthe owner of Severin-Partners A/S, a consulting company based in Copenhagen, Denmark. He was previously head of sales for Novartis and\nSales Manager at AstraZeneca Pharmaceuticals and at GlaxoSmithKline.\n\n \n\n19\n\n \n\n \n\n*Christian\nHill-Madsen—Former Chairman of our Board of Directors.*Mr. Hill-Madsen joined the Nordicus Partners Corporation Board in January\n2023. He has over 25 years of experience working as a headhunter dedicated to the Life Science Industry in the Nordics, mastering the\nfine art of finding the best candidates for the right job, in all aspects of the healthcare solution program from Headhunting and Recruitment,\nSalesforce Optimization, Assessment to Organizational Development, etc. He was the CEO of Life Science Power House ApS, a Denmark-based\nlife science advisory and consultancy firm, from 2018 to 2023. From 2013 to 2018 he was the Founder and CEO of the life science headhunting\nfirm, Hill-Consult.\n\n \n\n*Henrik\nKeller – Director.* Mr. Keller has more than four decades of experience in the corporate sector, in which he has a proven track\nrecord of delivering excellent performances. Mr. Keller possesses a unique set of strategical, managerial and sales capabilities, which\nhas been key in the documented success he has delivered to the companies he has been, and are currently involved with, serving in various\npositions as Owner, General Manager, Sales Manager, Consultant/Advisor, Board Member. He has been an independent business consultant\nsince 2009. Through his professional career, Mr. Keller has established a network which spans globally.\n\n \n\n*Bennett\nJ. Yankowitz—Chief Financial Officer and Director*. Mr. Yankowitz has more than 30 years of experience as a corporate attorney\nwith leading law firms, specializing in securities, financial and merger and acquisition transactions, and has a background in financial\nanalysis and real estate investment and development. He is of counsel to the law firm Shumaker Mallory LLP, and was previously of counsel\nto its predecessor firm Parker Shumaker Mills LLP. He is also chief executive officer of Gold Vault Capital, LLC. He was previously counsel\nto Kaye Scholer LLP and a partner of Heenan Blaikie and of Stroock & Stroock & Lavan LLP. From 2002 to 2014, he was a director\nof Proteus Energy Corporation, a California-based private oil and gas production and development company and was its Chief Executive\nOfficer from 2008 to 2014. He was chief financial officer and a member of the board of directors of RocketFuel Blockchain, Inc. from\n2015 to 2025. Mr. Yankowitz earned his B.A. degree in Mathematics from the University of California, Berkeley (1977), his J.D. degree\nfrom the University of Southern California (1980), where he was an editor of the Southern California Law Review, and his LL.M. degree\n(First Class Honours) from the University of Cambridge (1981), where he was an Evan Lewis-Thomas Scholar at Sidney Sussex College. He\nis a member of the California and New York bars.\n\n \n\nOur\nBoard has concluded that Mr. Yankowitz is an appropriate person to represent management on our Board of Directors given his position\nas our Chief Financial Officer, his professional credentials, and his understanding of corporate regulatory matters and merger and acquisition\nactivities.\n\n \n\n*Torben\nJensen—Director.*Mr. Jensen has more than 35 years of experience in finance and has during the years developed and funded projects\nand companies in real estate, energy, venture, life science and medico. He has previously been CEO and Chairman of the Board of two listed\ncompanies on Nasdaq. From 2019 to 2024 he was a Senior Partner in GK Partners ApS, a corporate finance house and a major shareholder\nin the Company, where he was the head of funding for projects. Furthermore, he has served as the Chief Executive Officer of AC Nordic\nsince December 2024, also a major shareholder in the Company.\n\n \n\n*Kim\nT. Mücke—Director.*Mr. Münke is a Danish state authorized public accountant (authorization deposited in 2025). He\nwas partner with Deloitte (Denmark) from 2002 to 2022 where he, among others, served as signing partner for various listed companies\nincluding companies that underwent IPO processes. In the years 2023-2024, Mr. Mücke was Head of Corporate Clients for BDO (Denmark).\nFrom January 1, 2025, Mr. Mücke has started as independent advisor, specialized in financial reporting, risk management and corporate\ngovernance. Mr. Mücke has a master’s degree in Auditing and Accounting from the Copenhagen Business School.\n\n \n\n*Andrew\nJ. Ritter—Director (Resigned).*Mr. Ritter has served as the Chief Executive Officer and a director of Cairns Health, an innovator in\nAI-powered remote care solutions supporting home and senior care, since September 2023. Previously, Mr. Ritter was the Chief\nExecutive Officer of Docbot, an AI-driven MedTech company, from January 2021 to December 2022. He also founded and served as Chief\nExecutive Officer of Ritter Pharmaceuticals, a biotechnology company focusing on gastrointestinal diseases, from March 2004 to May\n2020. In addition, he served as a founding director of Myosin Therapeutics, a biotech spin-out from Scripps Research, from October\n2021 to January 2025. Mr. Ritter earned a B.A. in political science at the University of Southern California and a Master of\nBusiness Administration at the Wharton School, University of Pennsylvania. On July 7, 2026, Andrew J. Ritter resigned from the Board of Directors\nof the Company, effective immediately.\n\n \n\n20\n\n \n\n \n\n**Code\nof Conduct and Ethics**\n\n \n\nWe\nhave adopted a Code of Ethics that allows for us to ensure that our disclosure controls and procedures remain effective. Our Code also\ndefines the standard of conduct expected by our chief executive officer and director. A copy of our Code of Ethics will be furnished\nwithout charge to any person upon written request. Requests should be sent to: Chief Executive Officer, Nordicus Partners Corporation,\n280 S. Beverly Dr., Suite 505, Beverly Hills, California 90212.\n\n \n\n**Section\n16(a) Beneficial Ownership Reporting Compliance**\n\n \n\nSection\n16(a) of the Securities Exchange Act of 1934 requires our executive officers, directors and persons who beneficially own more than 10%\nof a registered class of our securities to file reports of ownership and changes in ownership with the SEC. Based solely on a review\nof copies of such forms submitted to us, we believe that all persons subject to the requirements of Section 16(a) filed such reports\non a timely basis in fiscal year 2026.\n\n \n\n**Corporate\nGovernance and Guidelines**\n\n \n\nOur\nBoard of Directors has long believed that good corporate governance is important to ensure that we manage our company for the long-term\nbenefit of stockholders. During the past year, our Board of Directors has continued to review our governance practices in light of the\nSarbanes-Oxley Act of 2002 and recently revised SEC rules and regulations. We intend to implement internal corporate governance guidelines\nand practices when we have available resources to implement these guidelines and practices. Such guidelines and practices, when implemented,\nwill be furnished without charge to any person upon written request. Requests should be sent to: Chief Executive Officer, Nordicus Partners\nCorporation, 280 S. Beverly Dr., Suite 505, Beverly Hills, California 90212.\n\n \n\n**Committees\nof the Board of Directors**\n\n \n\nOn\nNovember 10, 2025, the Board created (1) a Nominating and Corporate Governance Committee, consisting of Peter Severin (Chairman), Kim\nT. Mücke and Andrew J. Ritter; (2) an Audit Committee, consisting of Kim T. Mücke (Chairman), Peter Severin and Andrew J. Ritter;\nand (3) a Compensation Committee, consisting of Andrew J. Ritter (Chairman), Peter Severin and Kim T. Mücke. The Board also adopted\na Code of Conduct and Ethics, an Insider Trading Policy, a Whistleblower Policy and a Compensation Recovery Policy.\n\n \n\nOn\nJuly 7, 2026, Andrew J. Ritter resigned from the Board of Directors of the Company, effective immediately. He also resigned from the\nAudit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board.\n\n \n\n**Director\nIndependence**\n\n \n\nWe\nare not currently subject to listing requirements of any national securities exchange or inter-dealer quotation system which has requirements\nthat a majority of the Board be “independent” and, as a result, we are not at this time required to have our Board comprised\nof a majority of “Independent Directors.” As of the date of this Report, two of our directors are considered to be independent."}